Esteban Martínez1, Esteban Jódar Gimeno2, Rebeca Reyes García3, Pedro Carpintero4, José Luis Casado5, Javier Del Pino Montes6, Pere Domingo Pedrol7, Vicente Estrada8, Jorge Maalouf9, Eugenia Negredo10, Antonio Ocampo11, Manuel Muñoz-Torres12. 1. Unidad de Enfermedades Infecciosas, Hospital Clínic, Barcelona, España. 2. Servicio de Endocrinología, Hospital Universitario Quirón, Madrid, España. 3. Unidad de Endocrinología, Hospital General Universitario Rafael Méndez, Lorca, Murcia, España. Electronic address: rebecarg@yahoo.com. 4. Servicio de Traumatología, Hospital Universitario Reina Sofía, Córdoba, España. 5. Servicio de Enfermedades Infecciosas, Hospital Ramón y Cajal, Madrid, España. 6. Servicio de Reumatología, Hospital Universitario de Salamanca, Salamanca, España. 7. Servicio de Medicina Interna, Hospital de la Santa Creu i Sant Pau, Barcelona, España. 8. Medicina Interna/Enfermedades Infecciosas, Hospital Clínico San Carlos, Madrid, España. 9. Unidad de Metabolismo Mineral, Departamento de Medicina Interna, Hospital de la Santa Creu i Sant Pau, Barcelona, España. 10. Servicio de Medicina Interna, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, España. 11. Unidad VIH, Hospital Xeral-Cies, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Pontevedra, España. 12. Unidad de Metabolismo Óseo, Servicio de Endocrinología, Hospital Universitario San Cecilio, Granada, España.
Abstract
OBJECTIVE: To provide practical recommendations for the evaluation and treatment of metabolic bone disease in human immunodeficiency virus (HIV) patients. PARTICIPANTS: Members of scientific societies related to bone metabolism and HIV: Grupo de Estudio de Sida (GeSIDA), Sociedad Española de Endocrinología y Nutrición (SEEN), Sociedad Española de Investigación Ósea y del Metabolismo Mineral (SEIOMM), and Sociedad Española de Fractura Osteoporótica (SEFRAOS). METHODS: A systematic search was carried out in PubMed, and papers in English and Spanish with a publication date before 28 May 2013 were included. Recommendations were formulated according to GRADE system (Grading of Recommendations, Assessment, Development, and Evaluation) setting both their strength and the quality of supporting evidence. Working groups were established for each major part, and the final resulting document was later discussed in a face-to-face meeting. All the authors reviewed the final written document and agreed with its content. CONCLUSIONS: The document provides evidence-based practical recommendations on the detection and treatment of bone disease in HIV-infected patients.
OBJECTIVE: To provide practical recommendations for the evaluation and treatment of metabolic bone disease in human immunodeficiency virus (HIV) patients. PARTICIPANTS: Members of scientific societies related to bone metabolism and HIV: Grupo de Estudio de Sida (GeSIDA), Sociedad Española de Endocrinología y Nutrición (SEEN), Sociedad Española de Investigación Ósea y del Metabolismo Mineral (SEIOMM), and Sociedad Española de Fractura Osteoporótica (SEFRAOS). METHODS: A systematic search was carried out in PubMed, and papers in English and Spanish with a publication date before 28 May 2013 were included. Recommendations were formulated according to GRADE system (Grading of Recommendations, Assessment, Development, and Evaluation) setting both their strength and the quality of supporting evidence. Working groups were established for each major part, and the final resulting document was later discussed in a face-to-face meeting. All the authors reviewed the final written document and agreed with its content. CONCLUSIONS: The document provides evidence-based practical recommendations on the detection and treatment of bone disease in HIV-infectedpatients.
Keywords:
Bone metabolism; Enfermedad metabólica ósea; Human immunodeficiency virus; Osteoporosis; Recomendaciones; Recommendations; Virus de la inmunodeficiencia humana; Vitamin D; Vitamina D
Authors: Sara Bañón; Marta Rosillo; Ana Gómez; María J Pérez-Elias; Santiago Moreno; José Luis Casado Journal: Endocrine Date: 2014-11-29 Impact factor: 3.633
Authors: Ana Lucia L Munhoz Lima; Priscila Rosalba Oliveira; Vladimir C Carvalho; Alexandre Leme Godoy-Santos; Leandro Ejnisman; Claudia R Oliveira; David E Uip; Maria Irma S Duarte Journal: HIV AIDS (Auckl) Date: 2018-05-25